Dexmedetomidina como coadyuvante en bloqueos de nervio periférico

González, Andrés

doi:10.20986/resed.2018.3695/2018

Cited by 2 publications

(1 citation statement)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…15 Its addition in central neuraxial blocks and various nerve blocks has shown to decrease block latency, increase duration of motor block and period of analgesia. [16][17][18] Wang et al found that ropivacaine with dexmedetomidine in ESPB for modified radical mastectomy (MRM) was found to decrease VAS and analgesic consumption in the postoperative period when compared to plain ropivacaine without any adjunct. 19 Similar to dexmedetomidine, dexamethasone has also been in used in regional anaesthesia as additive for a very long period of time.…”

Section: Discussionmentioning

confidence: 99%

Dexmedetomidine versus dexamethasone as adjunct to ropivacaine in erector spinae plane block for patients undergoing breast surgery: a randomized, prospective, double blinded study

Basing¹,

Deka²,

Majumdar³

2021

Int J Res Med Sci

View full text Add to dashboard Cite

Background: Loco-regional anaesthesia (GA) has been extensively applied in the clinical field for achieving post-operative analgesia. Erector spinae plane block (ESPB) which is a novel inter-fascial plane block has been widely used for breast surgery. Dexmedetomidine and dexamethasone as an adjunct to local anaesthesia have been widely reported to reduce postoperative pain and analgesic consumption but there are no studies comparing both these drugs in ESPB for breast surgery.Methods: Sixty ASA I-II patients scheduled for breast surgery were randomly allocated into two groups-Group DX and group DM. Group DX received 20 ml ropivacaine 0.2% with dexmedetomidine 0.5 mcg/kg while group DM received 20 ml ropivacaine 0.2 % with 8 mg dexamethasone in ESPB preemptively. All the patients were induced with standard GA and extubated at the end of surgery. In the post-operative period visual analogue scale (VAS) pain score, total tramadol consumption, time for first rescue analgesia and side effects were noted for 24 hours.Results: The demographical parameters were comparable between both the groups. The VAS score, total tramadol consumption and time for first rescue analgesia were both similar in both the groups without any significant difference. No side effects were noted in any patients in both the groups.Conclusions: Dexmedetomidine (0.5 mcg/kg) and dexamethasone (8 mg) as an adjunct to ropivacaine reduces postoperative pain and analgesic consumption with no significant difference when used in ESPB for patients undergoing breast surgery without any side effects.

show abstract

Section: Discussionmentioning

confidence: 99%

Dexmedetomidine versus dexamethasone as adjunct to ropivacaine in erector spinae plane block for patients undergoing breast surgery: a randomized, prospective, double blinded study

Basing¹,

Deka²,

Majumdar³

2021

Int J Res Med Sci

View full text Add to dashboard Cite

show abstract

Implementación de la dexmedetomidina en unidades de cuidados intensivos y durante el período perioperatorio

Peña Montoya

2024

Rev. Cun.

View full text Add to dashboard Cite

PROBLEMA: la dexmedetomidina es un fármaco utilizado en unidades de pacientes críticos y durante el periodo perioperatorio. Sin embargo, existe la necesidad de describir y comprender su implementación actual en estos contextos, así como evaluar beneficios, efectos adversos y aplicaciones específicas. OBJETIVO: describir la implementación de la dexmedetomidina en pacientes de cuidados intensivos y durante el período perioperatorio. MÉTODO: se realizó una investigación profunda de artículos de revistas médicas llevando a cabo lectura crítica de los mismos, se procedió a la extracción y organización de la información relevante. RESULTADOS: la dexmedetomidina demuestra ser una opción terapéutica valiosa en unidades de cuidados intensivos y durante el período perioperatorio. Su uso adecuado puede mejorar la calidad de la sedación, el control del dolor y los resultados clínicos de los pacientes. No obstante, es necesario considerar cuidadosamente los efectos adversos potenciales y las condiciones específicas de cada paciente antes de su implementación. CONCLUSIÓN: la implementación actual de la dexmedetomidina en pacientes durante el período perioperatorio y en unidades de cuidados intensivos tiene relevancia, su aplicación se ha fundamentado en la capacidad para proporcionar sedación adecuada, manejo del dolor excepcional y mantener la estabilidad hemodinámica en dichos contextos.

show abstract

Dexmedetomidina como coadyuvante en bloqueos de nervio periférico

Abstract: Instrucciones de citación para el artículo / Citation instructions for the article: Rojas Gonzalez Andres. Dexmedetomidina como coadyuvante en bloqueos de nervio periférico / Dexmedetomidine as peripheral nerve block adjuvant. Rev. Soc.

Cited by 2 publications

References 34 publications

Dexmedetomidine versus dexamethasone as adjunct to ropivacaine in erector spinae plane block for patients undergoing breast surgery: a randomized, prospective, double blinded study

Dexmedetomidine versus dexamethasone as adjunct to ropivacaine in erector spinae plane block for patients undergoing breast surgery: a randomized, prospective, double blinded study

Implementación de la dexmedetomidina en unidades de cuidados intensivos y durante el período perioperatorio

Contact Info

Product

Resources

About